Nanofluidic device delivered controlled doses
People with chronic diseases like arthritis, diabetes and heart disease may one day forego the daily regimen of pills and, instead, receive a scheduled dosage of medication through a grape-sized implant that is remotely controlled.
Researchers from Houston Methodist successfully delivered continuous, predetermined dosages of two chronic disease medications using a nanochannel delivery system (nDS) that they remotely controlled using Bluetooth technology. The nDS device provides controlled release of drugs without the use of pumps, valves or a power supply for possibly up to year without a refill for some patients. This technology will be tested in space next year.
A proof-of-concept paper recently published in Lab on a Chip (online June 25) explains how the Houston Methodist nanomedicine researchers accomplished long-term delivery of drugs for rheumatoid arthritis and high blood pressure, medications that are often administered at specific times of the day or at varying dosages based on patient needs.
“We see this universal drug implant as part of the future of health care innovation. Some chronic disease drugs have the greatest benefit of delivery during overnight hours when it’s inconvenient for patients to take oral medication. This device could vastly improve their disease management and prevent them from missing doses, simply with a medical professional overseeing their treatment remotely,” said Alessandro Grattoni, Ph.D., corresponding author and chair of the department of nanomedicine at Houston Methodist Research Institute.
Grattoni and the Houston Methodist researchers have worked on implantable nanochannel delivery systems to regulate the delivery of a variety of therapies for medical issues ranging from HIV-prevention to cancer. As basic research progresses with the remote-controlled device, the Houston Methodist technology is planned for extreme remote communication testing on the International Space Station in 2020. The team hopes that one day the system will be widely available to clinicians to treat patients remotely via telemedicine. This could provide both an improvement in the patients’ quality of life and a reduction of cost to the health care system.
The battery-powered implant contains a microchip that is Bluetooth enabled and relies on wireless communication. To prove the technology worked as planned, the microchip was programmed for three different drug release settings – standard, decreased and increased. With each setting, a specific voltage was applied to a silicon nanochannel within the implant to control drug release.
Current drug delivery devices, such as pain or insulin implants, rely on pumping mechanisms or external ports and typically need refills every couple of months. The Houston Methodist device is implanted under the skin and uses a nanofluidic membrane made with similar technology used in the silicon semiconductor industry. The drug dosage and schedule can be tailored to each patient, and the implant delivers the drugs for many months, even a year, before refills are needed.
According to the CDC, chronic diseases are among the most common, costly and preventable of all medical problems.
The Latest on: Drug delivery implant
via Google News
The Latest on: Drug delivery implant
- SpaceX sends drug delivery implants to space station for studyon August 31, 2021 at 4:15 am
NASA has opened another front in the long-running exploration of drug delivery in space. The latest initiative sees implantable drug delivery devices sent to the International Space Station on a ...
- Research Round-Up: 7 New HIV Prevention Options In The Pipelineon August 30, 2021 at 2:33 am
One of the most vibrant areas of HIV research these days is the search for new, more convenient ways to use antiretroviral medicines (ARVs) to prevent HIV ...
- Treatment That May Be Viable For Human Brain Cancer Discoveredon August 27, 2021 at 10:06 pm
A new STING treatment induces immunological responses that allow the immune system to fight otherwise immunological resistant glioblastoma cancer cells, researchers report.
- FDA Approves Medtronic's Next-Gen Evolut FX TAVR Systemon August 24, 2021 at 10:42 am
The system features enhancements to the valve and delivery system to make it easier to use and provide greater visualization capabilities.
- Inflammasome develops combo HIV/birth control implanton August 23, 2021 at 7:41 am
Thanks in part to grants from the Gates Foundation, the company has come up with a bioerodible implant that combines HIV prevention and birth control.
- 4D Printing in Healthcare Market Overview, Merger and Acquisitions , Drivers, Restraints and Industry Forecast By 2027on August 20, 2021 at 7:47 am
The increasing technological advancements in 3D printing and rising demand for innovative products in biomedical implants are expected to be some major drivers for the market the global 4D Printing in ...
- Port Delivery System with ranibizumab targets nAMDon August 19, 2021 at 5:06 am
Findings from the Archway trial showed that the PDS effect is long-lasting, consistent, and comparable to those seen with monthly injections.
- Global Medical Implant Market Share 2021 Business Opportunities, Current Trends, Market Size, Share, Challenges and CAGR Value and Forecast to 2025on August 19, 2021 at 1:10 am
Final Report will add the analysis of the impact of COVID-19 on this industry” Global “Medical Implant Market” report ...
- 4D Printing in Healthcare Market Trend, Forecast, Drivers, Restraints, Company Profiles and Key Players Analysis by 2027on August 18, 2021 at 9:50 am
D Printing in Healthcare market was valued at USD 4.7 million in 2019 and is expected to reach USD 39.3 million by the year 2027, at a CAGR of 29.8%. The introduction of 4D printing has emerged from ...
- Hearing implants demand will grow by 7.31% CAGR through 2031, supplemented by surging sales of cochlear implants: FMIon August 18, 2021 at 6:43 am
A recent study Future Market Insights (FMI) provides incisive coverage on the key drivers and restraints that are likely to affect hearing implant sales through the next ten years. The market has been ...
via Bing News